Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayur Choudhary

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|October 3, 2015
A Brief Discussion on Lipid Activated Nuclear Receptors and their Potential Role in Regulating Microglia in Age-Related Macular Degeneration (AMD)Mayur Choudhary, Goldis Malek
Advances in Experimental Medicine and Biology|July 13, 2023
CD68: Potential Contributor to Inflammation and RPE Cell DystrophyMayur Choudhary, Goldis Malek
Advances in Experimental Medicine and Biology|December 30, 2019
A Review of Pathogenic Drivers of Age-Related Macular Degeneration, Beyond Complement, with a Focus on Potential Endpoints for Testing Therapeutic Interventions in Preclinical StudiesMayur Choudhary, Goldis Malek
International Journal of Molecular Sciences|September 19, 2020
The Aryl Hydrocarbon Receptor: A Mediator and Potential Therapeutic Target for Ocular and Non-Ocular Neurodegenerative DiseasesMayur Choudhary, Goldis Malek
Progress in Retinal and Eye Research|October 11, 2022
Potential therapeutic targets for age-related macular degeneration: The nuclear optionMayur Choudhary, Goldis Malek
Journal of Biomolecular Screening|July 27, 2016
Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal DiseasesMayur Choudhary, Goldis Malek
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 27, 2018
Suppression of aberrant choroidal neovascularization through activation of the aryl hydrocarbon receptorMayur Choudhary, Stephen Safe, Goldis Malek
Expert Opinion on Drug Discovery|February 1, 2018
Models of retinal diseases and their applicability in drug discoveryGoldis Malek, Julia Busik, Maria B Grant, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 19, 2022
Characterization and identification of measurable endpoints in a mouse model featuring age-related retinal pathologies: a platform to test therapiesMayur Choudhary, Faryan Tayyari, James T Handa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 14, 2021
Osteopontin accumulates in basal deposits of human eyes with age-related macular degeneration and may serve as a biomarker of agingMichael Lekwuwa, Mayur Choudhary, Eleonora M Lad, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|October 3, 2015
A Brief Discussion on Lipid Activated Nuclear Receptors and their Potential Role in Regulating Microglia in Age-Related Macular Degeneration (AMD)Mayur Choudhary, Goldis Malek
Advances in Experimental Medicine and Biology|July 13, 2023
CD68: Potential Contributor to Inflammation and RPE Cell DystrophyMayur Choudhary, Goldis Malek
Advances in Experimental Medicine and Biology|December 30, 2019
A Review of Pathogenic Drivers of Age-Related Macular Degeneration, Beyond Complement, with a Focus on Potential Endpoints for Testing Therapeutic Interventions in Preclinical StudiesMayur Choudhary, Goldis Malek
International Journal of Molecular Sciences|September 19, 2020
The Aryl Hydrocarbon Receptor: A Mediator and Potential Therapeutic Target for Ocular and Non-Ocular Neurodegenerative DiseasesMayur Choudhary, Goldis Malek
Progress in Retinal and Eye Research|October 11, 2022
Potential therapeutic targets for age-related macular degeneration: The nuclear optionMayur Choudhary, Goldis Malek
Journal of Biomolecular Screening|July 27, 2016
Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal DiseasesMayur Choudhary, Goldis Malek
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 27, 2018
Suppression of aberrant choroidal neovascularization through activation of the aryl hydrocarbon receptorMayur Choudhary, Stephen Safe, Goldis Malek
Expert Opinion on Drug Discovery|February 1, 2018
Models of retinal diseases and their applicability in drug discoveryGoldis Malek, Julia Busik, Maria B Grant, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 19, 2022
Characterization and identification of measurable endpoints in a mouse model featuring age-related retinal pathologies: a platform to test therapiesMayur Choudhary, Faryan Tayyari, James T Handa, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 14, 2021
Osteopontin accumulates in basal deposits of human eyes with age-related macular degeneration and may serve as a biomarker of agingMichael Lekwuwa, Mayur Choudhary, Eleonora M Lad, et al.
Pageof 2